Dispelling Dampness, Relieving Turbidity and Dredging Collaterals Decoction, Attenuates Potassium Oxonate-Induced Hyperuricemia in Rat Models
Hai-bo Liu,Min Yang,Wan Li,Ting Luo,Yang Wu,Xiang-yu Huang,Yao-lei Zhang,Tao Liu,Yong Luo
DOI: https://doi.org/10.2147/DDDT.S419130
2023-08-03
Abstract:Hai-bo Liu, 1, &ast Min Yang, 2, &ast Wan Li, 2 Ting Luo, 2 Yang Wu, 2 Xiang-yu Huang, 2 Yao-lei Zhang, 3 Tao Liu, 2 Yong Luo 2, &ast 1 Department of Biomedical Engineer, General Hospital of Western Theater Command, Chengdu, Sichuan, People's Republic of China; 2 Department of Traditional Chinese Medicine, General Hospital of Western Theater Command, Chengdu, Sichuan, People's Republic of China; 3 Basic Medical Laboratory, General Hospital of Western Theater Command, Chengdu, Sichuan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yong Luo, Department of Traditional Chinese Medicine, General Hospital of Western Theater Command, Chengdu, Sichuan, 610083, People's Republic of China, Tel +86 28-86571619, Email Purpose: Dispelling dampness, relieving turbidity and dredging collaterals decoction (DED), is a traditional Chinese medicine used in the treatment of hyperuricemia. We aimed to explore the effect and mechanism of DED in the treatment of hyperuricemia. Methods: The effects of DED (9.48, 4.74, and 2.37 g/kg/d) on potassium oxonate (750 mg/kg/d)-induced hyperuricemia in rats were evaluated by serum uric acid (UA), creatinine (CRE), blood urea nitrogen (BUN), and renal pathological changes. Network pharmacology was used to identify the effective components and targets of DED, and the key targets and signaling pathways for its effects on hyperuricemia were screened. Molecular docking was used to predict the action of DED. H&E, immunohistochemistry, WB, and PCR were used to validate the network pharmacology results. Results: DED can effectively alleviate hyperuricemia, inhibit UA, CRE, BUN, and xanthine oxidase (XOD) activity, and reduce renal inflammatory cell infiltration and glomerular atrophy. The experiment identified 27 potential targets of DED for hyperuricemia, involving 9 components: wogonin, stigmasterol 3-O-beta-D-glucopyranoside, 3β-acetoxyatractylone, beta-sitosterol, stigmasterol, diosgenin, naringenin, astilbin, and quercetin. DED can relieve hyperuricemia mainly by inhibiting RAGE, HMGB1, IL17R, and phospho-TAK1, and by regulating the AGE-RAGE and IL-17 signaling pathways. Conclusion: DED can alleviate hyperuricemia by inhibiting XOD activity and suppressing renal cell apoptosis and inflammation via the AGE-RAGE signaling pathway and IL-17 signaling pathway. This study provides a theoretical basis for the clinical application of DED. Graphical Keywords: dispelling dampness, relieving turbidity, dredging collaterals, hyperuricemia, network pharmacology Graphical Hyperuricemia is an independent risk factor for diseases such as gout, chronic kidney disease, hypertension, cardiovascular and cerebrovascular diseases, and diabetes; and is also an independent predictor of premature death. Hyperuricemia is caused by purine metabolism disorders, 1 characterized by elevated serum uric acid levels. Although commonly used urate-lowering drugs such as allopurinol, febuxostat, and benzbromarone have some effectiveness, their long-term use leads to significant adverse effects. 2,3 Therefore, finding a safe and effective drug is urgent. Studies have proven that hyperuricemia is a systemic disease that can induce renal inflammation by activating NLRP3, promote cardiomyocyte apoptosis through ROS expression upregulation, and regulate TGF-β pathways to promote cell autophagy 4,5 According to the theory of traditional Chinese medicine, "dispelling dampness, relieving turbidity and dredging collaterals" are the basic treatment principles of hyperuricemia renal injury. 6,7 "Dispelling dampness, relieving turbidity and dredging collaterals decoction (DED)" consists of yam rhizome, rhizoma smilacis glabrae, cortex phellodendri, Atractylodis rhizoma, medicinal cyathula root, semen coicis , and Ligusticum wallichii. Atractylodis rhizoma and semen coicis contain various anti-inflammatory and anti-apoptotic ingredients that are used to dispel dampness. 8,9 The yam rhizome, rhizoma smilacis glabrae and cortex phellodendri play a significant role in regulating uric acid transporters and glucose transporters in renal tubules 10–12 and are used to relieve turbidity. Magnograndiolide is the main component of medicinal cyathula root and Ligusticum wallichii in promoting blood circulation and removal of blood stasis and has anti-inflammatory, antioxidant and antifibrosis effects 13 used for promoting dredging collaterals. The above drugs are used together to -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal